Ancora Heart Enrolls First Patient in European Multi-center Study of AccuCinch Heart Failure Therapy

Aug 14, 2019 | DAIC Articles

August 14, 2019 — Ancora Heart Inc. announced the first patient was enrolled in the CorCinch EU study, a European multi-center clinical evaluation of the AccuCinch Ventricular Repair System as a treatment for patients with reduced ejection fraction systolic heart failure (HFrEF).